XAGEW Longevity Health Holdings, Inc.: institutional ownership and insider trading
2 funds reported holding $415 of Longevity Health Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 0 funds selling out; over the last 12 months insiders bought $200K and sold $0 on the open market; over its last four quarters it reported revenue of $1.69M and net income of −$6.83M.
XAGEW revenue and earnings
- Quarter ended Jun 30, 2026: revenue $396K, net income −$1.88M
- Quarter ended Mar 31, 2026: revenue $392K, net income −$1.43M, EPS -0.75
- Quarter ended Dec 31, 2025: revenue $473K, net income −$2.08M, EPS -0.92
- Quarter ended Sep 30, 2025: revenue $426K, net income −$1.43M, EPS -0.83
Largest institutional holders of XAGEW
- CLEAR STREET LLC — $401
- Ancora Advisors LLC — $14
Recent XAGEW insider trades
- Mar 16, 2026: Ajjarapu J. Ram bought 689,656 shares ($200K)
5%+ owners
- Ajjarapu J. Ram: 27.9% (Schedule 13D, filed Apr 8, 2026)
Who owns the most XAGEW stock?
The largest institutional holders of Longevity Health Holdings, Inc. in the latest 13F filings are CLEAR STREET LLC ($401), Ancora Advisors LLC ($14).
Are insiders buying or selling XAGEW?
Over the last 12 months insiders bought $200K and sold $0 of Longevity Health Holdings, Inc. stock on the open market (SEC Form 4).
What was XAGEW's revenue last quarter?
Longevity Health Holdings, Inc. reported revenue of $396K for the quarter ended June 30, 2026, with net income of −$1.88M.